Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing R&D activities in pharmaceutical and biotechnology industries
3.2.1.2 Rising demand for personalized medicine and precision healthcare
3.2.1.3 Advancements in computational technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Data quality and availability
3.2.2.2 Algorithmic bias and interpretability
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Software
5.3 Services
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Chemical analysis
6.2.1 Chemical databases
6.2.2 Chemometrics
6.2.3 Molecular modelling
6.2.4 Other chemical analysis types
6.3 Drug discovery and validation
6.4 Virtual screening
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical and biotechnology companies
7.3 Academic and research institutes
7.4 Contract research organizations (CROs)
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 ACD/Labs, Inc.
9.2 Agilent Technologies, Inc.
9.3 Bio-Rad Laboratories, Inc.
9.4 BioSolveIT GmbH
9.5 Cadence Molecular Sciences LLC
9.6 Centara
9.7 ChemAxon Ltd
9.8 Chemical Computing Group ULC
9.9 Collaborative Drug Discovery Inc.
9.10 Dassault Systèmes
9.11 Jubilant Biosys Ltd
9.12 Molecular Discovery Ltd
9.13 OpenEye Scientific Software, Inc.
9.14 PerkinElmer Inc.
9.15 Schrödinger, Inc.
9.16 Scilligence
